Wei Lü

13.7k total citations · 4 hit papers
182 papers, 10.2k citations indexed

About

Wei Lü is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Wei Lü has authored 182 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 52 papers in Biomedical Engineering and 33 papers in Biomaterials. Recurrent topics in Wei Lü's work include Nanoplatforms for cancer theranostics (35 papers), Nanoparticle-Based Drug Delivery (29 papers) and Gold and Silver Nanoparticles Synthesis and Applications (17 papers). Wei Lü is often cited by papers focused on Nanoplatforms for cancer theranostics (35 papers), Nanoparticle-Based Drug Delivery (29 papers) and Gold and Silver Nanoparticles Synthesis and Applications (17 papers). Wei Lü collaborates with scholars based in China, United States and Germany. Wei Lü's co-authors include Xinguo Jiang, Chun Li, Qian Huang, Qizhi Zhang, Marites P. Melancon, Shaoli Song, Liangran Guo, Rui Zhang, Kaili Hu and Mei Tian and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Wei Lü

178 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Chelator-Free Multifunctional [⁶⁴Cu]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation Therapy

2010 639 citations Rui Zhang, Wei Lü et al. profile →
Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells

2010 571 citations Wei Lü, Qian Huang et al. profile →
Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles

2014 474 citations Wei Lü et al. ACS Nano profile →
ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice

2024 50 citations Tao Zhuang, Meihua Chen et al. Nature Communications profile →

Peers

Countries citing papers authored by Wei Lü

Since Specialization

Citations

This map shows the geographic impact of Wei Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lü more than expected).

Fields of papers citing papers by Wei Lü

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lü. The network helps show where Wei Lü may publish in the future.

Co-authorship network of co-authors of Wei Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Lü. A scholar is included among the top collaborators of Wei Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Lü. Wei Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineered Substrate‐Free Small Molecules for Enhanced Raman Scattering and Photothermal Conversion Efficiency 2025 ·Advanced Science ·Sheng Yu, Shuai Gao, Yongming Zhang, Sihang Zhang, Jingwen Sun, Wenxian Zhang, (unknown), Kai Cui, Zeyu Xiao, Wei Lü	1
2	LBA1 Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with high-risk human epidermal growth factor receptor 2–positive (HER2+) primary breast cancer (BC) with residual invasive disease after neoadjuvant therapy (tx): Interim analysis of DESTINY-Breast05 2025 ·Annals of Oncology ·Charles E. Geyer, (unknown), (unknown), Chiun‐Sheng Huang, Carlos H. Barrios, Judith A. Abraham, (unknown), (unknown), (unknown), S-A. Im, (unknown), Huili Li, Yibin Wang, (unknown), S-B. Kim, E. Mathias, Yusuke Sato, Wei Lü, Hanan Abdel‐Monem, Sibylle Loibl	1
3	Inhibitory effect of aqueous extract of Scrophularia ningpoensis on β-cell pyroptosis in diabetic mice 2024 ·Journal of Functional Foods ·(unknown), (unknown), Xiaohan Li, Shiqi Chen, Jun Zhou, Wei Lü, Xiangxiang Fu, Xiang Qin, Yu Zhang, Yonghong Zhang, Qibin Wang, Li Chen, Tao Zheng	1
4	Tumour cell-expressed PD-L1 reprograms lipid metabolism via EGFR/ITGB4/SREBP1c signalling in liver cancer 2024 ·JHEP Reports ·Man Zhao, Hongfeng Yuan, (unknown), Yufei Wang, Yanan Bu, (unknown), Lina Zhao, (unknown), Haolin Yun, (unknown), Jinyan Feng, Chunyu Hou, Shuai Wang, (unknown), Wei Lü, (unknown)	11
5	A rotating machinery feature enhancement method based on improved symplectic geometry mode component sparsity 2024 ·Measurement ·Huaqing Wang, Jingjing Yan, Wei Lü, Junlin Li, Liuyang Song, (unknown)	1
6	ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice breakdown → 2024 ·Nature Communications ·Tao Zhuang, Meihua Chen, (unknown), Jing Wang, (unknown), Ting Meng, (unknown), Yan Li, (unknown), (unknown), Donghua Hu, (unknown), Li Zhang, Aijun Sun, Wei Lü, Guannan Zhang, Junli Zuo, Cheng‐Chao Ruan	50
7	CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy 2023 ·Histopathology ·Mario L. Marques‐Piubelli, Do H. Kim, L. Jeffrey Medeiros, Wei Lü, (unknown), (unknown), (unknown), Edwin R. Parra, Chi Young Ok, (unknown), Luisa M. Solis, Yago Nieto, Raphaël Steiner, Sairah Ahmed, Francisco Vega	10
8	Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease 2022 ·ACS Nano ·Kang Qian, Xiaoyan Bao, Yixian Li, Pengzhen Wang, Qian Guo, Peng Yang, Shuting Xu, (unknown), Ran Meng, Yunlong Cheng, Dongyu Sheng, Jinxu Cao, Minjun Xu, Jing Wu, Tianying Wang, Yonghui Wang, Qiong Xie, Wei Lü, Qizhi Zhang	67
9	A time-frequency sparse strategy based on optimal flux atom and scale lp approximation operator 2022 ·Measurement Science and Technology ·(unknown), Wei Lü, Pengxin Wang, Liuyang Song, Huaqing Wang	4
10	Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy 2021 ·Alzheimer s Research & Therapy ·Yun‐Beom Choi, Ambrose A. Dunn-Meynell, Michelle Marchese, Benjamin M. Blumberg, (unknown), Peter C. Dowling, Wei Lü	6
11	Precise gene delivery systems with detachable albumin shell remodeling dysfunctional microglia by TREM2 for treatment of Alzheimer's disease 2021 ·Biomaterials ·Pengzhen Wang, Peng Yang, Kang Qian, Yixian Li, Shuting Xu, Ran Meng, Qian Guo, Yunlong Cheng, Jinxu Cao, Minjun Xu, Wei Lü, Qizhi Zhang	38
12	Facile synthesis of a well-defined heteroatom-containing main chain polycarbonate for activated intracellular drug release 2020 ·Materials Chemistry Frontiers ·(unknown), (unknown), (unknown), Wei Lü, Zhongchen Song, Yan Zhang	5
13	Regulation of Autophagy by Glycolysis in Cancer 2020 ·Cancer Management and Research ·Ying Chu, (unknown), Wei Lü, Xiumei Sheng, Shengjun Wang, Huaxi Xu, Jie Ma	42
14	One-shot synthesis and solution properties of ROS/pH responsive methoxy poly(ethylene glycol)-b-polycarbonate 2019 ·Polymer Chemistry ·Yan Zhang, Yue Xu, Chao Wei, (unknown), (unknown), (unknown), Wei Lü	15
15	Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease 2018 ·Journal of Controlled Release ·Pengzhen Wang, Xiaoyao Zheng, Qian Guo, Peng Yang, Xiaoying Pang, Kang Qian, Wei Lü, Qizhi Zhang, Xinguo Jiang	128
16	Inhibition of C5a prevents IL-1β-induced alternations in rat synoviocytes in vitro 2018 ·Molecular and Cellular Probes ·Wei Lü, Lin Wang, (unknown), Wen Wang, Yu Chen	1
17	Tumor Site–Specific Silencing of NF-κB p65 by Targeted Hollow Gold Nanosphere–Mediated Photothermal Transfection 2010 ·Cancer Research ·Wei Lü, Guodong Zhang, Rui Zhang, Leo G. Flores, Qian Huang, Juri G. Gelovani, Chun Li	220
18	Targeted Photothermal Ablation of Murine Melanomas with Melanocyte-Stimulating Hormone Analog–Conjugated Hollow Gold Nanospheres 2009 ·Clinical Cancer Research ·Wei Lü, Chiyi Xiong, Guodong Zhang, Qian Huang, Rui Zhang, Jin Z. Zhang, Chun Li	259
19	Cationic Albumin–Conjugated Pegylated Nanoparticles Allow Gene Delivery into Brain Tumors via Intravenous Administration 2006 ·Cancer Research ·Wei Lü, (unknown), (unknown), Zhenjue She, Xinguo Jiang	176
20	[Epidemiological feature of metabolic syndrome in Shanghai residents aged 15 - 74 years]. 2006 ·PubMed ·Wei Lü, Meixia Liu, Rui Li, Hua Fu, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact